Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study.

Cimadevilla C, Cueff C, Hekimian G, Dehoux M, Lepage L, Iung B, Duval X, Huart V, Tubach F, Vahanian A, Messika-Zeitoun D.

Heart. 2013 Apr;99(7):461-7. doi: 10.1136/heartjnl-2012-303284. Epub 2013 Jan 24.

PMID:
23349346
2.

Natriuretic peptides in the management of aortic stenosis.

Bergler-Klein J.

Curr Cardiol Rep. 2009 Mar;11(2):85-93. Review.

PMID:
19236823
3.

[Biomarkers for the evaluation of valvular aortic stenosis].

Weber M, Hamm C.

Herz. 2006 Oct;31(7):658-63. Review. German.

PMID:
17072779
4.

B-type natriuretic peptides in acute coronary syndromes: implications in an aging population.

Krim SR, Vivo RP, de Lemos JA.

Clin Cardiol. 2012 Nov;35(11):682-5. doi: 10.1002/clc.22035. Epub 2012 Jul 3. Review.

5.

Natriuretic peptides for risk stratification of patients with valvular aortic stenosis.

Parikh V, Kim C, Siegel RJ, Arsanjani R, Rader F.

Circ Heart Fail. 2015 Mar;8(2):373-80. doi: 10.1161/CIRCHEARTFAILURE.114.001649. Review. No abstract available.

6.

C-reactive protein in aortic valve disease.

Sanchez PL, Mazzone AM.

Cardiovasc Ultrasound. 2006 Oct 16;4:37. Review. Retraction in: Sanchez PL, Mazzone AM. Cardiovasc Ultrasound. 2006;4:42.

7.

The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision.

Ross RD.

Pediatr Cardiol. 2012 Dec;33(8):1295-300. doi: 10.1007/s00246-012-0306-8. Epub 2012 Apr 5. Review.

PMID:
22476605
8.

Establishing prognosis in heart failure: a multimarker approach.

Ketchum ES, Levy WC.

Prog Cardiovasc Dis. 2011 Sep-Oct;54(2):86-96. doi: 10.1016/j.pcad.2011.03.003. Review.

PMID:
21875508
Items per page

Supplemental Content

Write to the Help Desk